全文获取类型
收费全文 | 1752篇 |
免费 | 103篇 |
国内免费 | 49篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 21篇 |
妇产科学 | 4篇 |
基础医学 | 56篇 |
口腔科学 | 11篇 |
临床医学 | 218篇 |
内科学 | 328篇 |
皮肤病学 | 1篇 |
神经病学 | 387篇 |
特种医学 | 55篇 |
外科学 | 162篇 |
综合类 | 286篇 |
预防医学 | 30篇 |
眼科学 | 51篇 |
药学 | 104篇 |
1篇 | |
中国医学 | 160篇 |
肿瘤学 | 2篇 |
出版年
2024年 | 2篇 |
2023年 | 18篇 |
2022年 | 54篇 |
2021年 | 85篇 |
2020年 | 59篇 |
2019年 | 31篇 |
2018年 | 56篇 |
2017年 | 49篇 |
2016年 | 58篇 |
2015年 | 62篇 |
2014年 | 108篇 |
2013年 | 100篇 |
2012年 | 122篇 |
2011年 | 99篇 |
2010年 | 86篇 |
2009年 | 82篇 |
2008年 | 74篇 |
2007年 | 83篇 |
2006年 | 62篇 |
2005年 | 73篇 |
2004年 | 49篇 |
2003年 | 57篇 |
2002年 | 41篇 |
2001年 | 36篇 |
2000年 | 33篇 |
1999年 | 16篇 |
1998年 | 24篇 |
1997年 | 14篇 |
1996年 | 25篇 |
1995年 | 18篇 |
1994年 | 22篇 |
1993年 | 22篇 |
1992年 | 14篇 |
1991年 | 19篇 |
1990年 | 14篇 |
1989年 | 10篇 |
1988年 | 12篇 |
1987年 | 14篇 |
1986年 | 15篇 |
1985年 | 16篇 |
1984年 | 15篇 |
1983年 | 7篇 |
1982年 | 11篇 |
1981年 | 12篇 |
1980年 | 8篇 |
1979年 | 2篇 |
1978年 | 6篇 |
1977年 | 3篇 |
1976年 | 3篇 |
1973年 | 1篇 |
排序方式: 共有1904条查询结果,搜索用时 15 毫秒
1.
m. fox † r. sweis † t. wong † & a. anggiansah 《Neurogastroenterology and motility》2007,19(10):798-803
Oesophageal spasm presents with dysphagia and chest pain. Current treatments are limited by poor efficacy and side effects. Studies in health and oesophageal dysmotility show that sildenafil reduces peristaltic pressure and velocity; however the clinical efficacy and tolerability in symptomatic oesophageal spasm remains uncertain. We provided open-label sildenafil treatment to two patients with severe, treatment resistant symptoms associated with oesophageal spasm. The effects of sildenafil on oesophageal function and symptoms were documented by high resolution manometry (HRM). Patients were followed up to assess the efficacy of maintenance treatment with sildenafil b.i.d. HRM revealed focal and diffuse spasm in the smooth muscle oesophagus that were associated with symptoms in both cases, especially on swallowing solids. Lower oesophageal sphincter function was normal. A therapeutic trial of 25-50 mg sildenafil suppressed oesophageal contraction almost completely for water swallows; however effective, coordinated peristalsis returned with reduced frequency of spasm for solid swallows. Dysphagia and chest pain resolved during the therapeutic trial and efficacy was maintained on maintenance treatment with 25-50 mg sildenafil b.i.d. without troublesome side effects. This report shows that sildenafil can improve oesophageal function and relieve dysphagia and chest pain in patients with oesophageal spasm in whom other treatments have failed. 相似文献
2.
张金立 《河北职工医学院学报》2010,27(3):32-33
目的探讨臂丛加强化麻醉后颈部抽动的原因及防治。方法对近年来在麻醉方法、用药相同,术后颈部抽动患者的观察治疗过程进行分析。结果臂丛麻醉并发颈部抽动给予充分镇静后可完全治愈。结论麻醉后并发颈部抽动为药物副作用及颈局部刺激的综合作用。 相似文献
3.
Facial muscle spasms, which are rare in adults, present a particularly difficult entity for the optometrist to recognise. The condition may not even manifest itself at an eye examination and the optometrist may have to rely on subjective symptoms to assist in the recognition of the condition. It is important to diagnose the condition correctly as specific and effective treatment is available. 相似文献
4.
对173例支气管哮喘特异性脱敏治疗的疗效及影响疗效的因素进行了分析。结果表明:显效为30.6%(53/173).有效为56.1%(97/173),无效为13.3%(23/173)。影响疗效的因素与病情的程度有关,而与年龄、病程、皮试阳性反应强弱及脱敏治疗前4个疗程内是否应用曲安缩松等无关。并对特异性脱敏治疗支气管哮喘的优缺点进行讨论。 相似文献
5.
200例择期胆囊切除+术中胆道造影患者分二组;芬太尼17ug/kg静注(F组,n=100)、哌替啶1mg/kg静注。评价两种麻醉性镇痛药致Oddi括约肌痉挛的发生率,结果:8例病人造影剂不能通过Oddi括约肌、十二指肠不显影,胆总管下端显示“鸟嘴样”或“假结石”影像,后者3例病人胆总管探查阴性,静注纳络酮0.4mg后,全部病例造影剂顺利进入十二指肠。结论:硬膜外麻醉辅用小剂量芬太尼/哌替啶时Odd 相似文献
6.
维拉帕米灌注治疗前列腺术后膀胱痉挛性疼痛的临床疗效观察 总被引:15,自引:2,他引:13
为探讨前列腺术后膀胱痉挛性疼痛的药物治疗效果,将26例前列腺增生行耻骨上经膀胱前列腺摘除术后频繁发作膀胱逼尿肌无抑制性收缩导致膀胱痉挛性疼痛者,按随机抽样法分为两组,第1组15例接受维拉帕米膀胱灌注治疗,第2组11例作为对照,不用任何可能影响下尿中功能的药物。 相似文献
7.
8.
Elliot L Dimberg Sheila E Crowe Joel M Trugman Russell H Swerdlow M Beatriz Lopes T David Bourne Ted M Burns 《Movement disorders》2007,22(3):407-411
We report the case of a woman with refractory celiac disease who developed abnormal spontaneous movements of the extremities and face consistent with myorhythmia. Investigation led to a diagnosis of encephalitis, confirmed by postmortem examination. The movements were likely caused by nonparaneoplastic encephalitis associated with refractory celiac disease. Etiologic and diagnostic considerations and treatment options are discussed. 相似文献
9.
Bradley J Katz John R Burroughs Richard L Anderson Shannon Bownds John D McCann 《Movement disorders》2007,22(2):231-234
We present a patient with a facial movement disorder that has characteristics of both blepharospasm and bilateral asynchronous hemifacial spasm. Because of the increased incidence of blepharospasm in patients with hemifacial spasm, our patient's clinical presentation is probably not a chance occurrence, but rather a manifestation of some predisposition for these two movement disorders. This unusual constellation of signs and symptoms challenges the current diagnostic criteria and suggests that some of these facial movement disorders may lie on a spectrum, rather than represent distinct entities. 相似文献
10.
Microvascular decompression for hemifacial spasm: postoperative neurologic follow-up and evaluation of life quality 总被引:2,自引:0,他引:2
K. Heuser E. Kerty P. K. Eide M. Cvancarova E. Dietrichs 《European journal of neurology》2007,14(3):335-340
Microvascular decompression (MVD) is an effective and safe treatment in hemifacial spasm (HFS). Postoperative evaluations are usually made by neurosurgeons. Follow-up studies performed by neurologists and postoperative quality of life (QoL) investigations are lacking. All 25 HFS patients operated with MVD in our centre between 2000 and 2004 were evaluated with the recently validated HFS-7 scheme, extended with the item 'sleep disturbance due to HFS' (HFS-8). The patients underwent a careful neurological examination median 3 years after the operation. The evaluation focused on clinical aspects, changes in blood pressure and time until observable effect of MVD. The evaluation of HFS-7 questionnaire and the extended form (HFS-8) showed significant improvement in QoL after MVD. Neurological outcome was in almost all cases excellent or good. Eleven (44%) patients had no neurological deficits at all. Only one patient had serious complications with ipsilateral facial palsy, deafness, balance problems and vertigo. The other patients had minor neurological findings or symptoms. Eighteen (72%) patients experienced early effect within 3 months after MVD; seven (28%) patients had late effect between 6 and 14 months. Median age of the patients with late effect (62.6 years) was significantly higher than in those with early effect (52.7 years). 相似文献